单侧丘脑底核联合对侧苍白球内侧部脑深部电刺激治疗帕金森病:一项症状定制刺激的初步研究
本研究回顾性纳入8例特发性帕金森病患者,采用单侧丘脑底核(STN)联合对侧苍白球内侧部(GPi)的脑深部电刺激(DBS)治疗,在基线、6个月和12个月随访评估运动与非运动症状。结果显示关药开机状态下UPDRS-III和TUG显著改善,12个月时生活质量提高、左旋多巴用量减少,开药状态下双侧刺激使步态与跌倒指标改善64%,未观察到不可逆不良事件。
要点
- 单侧STN联合对侧GPi的DBS可显著改善帕金森病患者关药开机状态下的运动症状。
- 12个月随访时患者生活质量提高且左旋多巴用量减少。
- 开药状态下双侧刺激对步态与跌倒指标改善达64%,未出现不可逆不良事件。
核心结论
- 单侧STN联合对侧GPi的DBS可能为部分帕金森病患者提供有效且耐受性良好的DBS治疗。
研究设计与样本
- 回顾性研究,纳入8例特发性帕金森病患者,接受单侧STN联合对侧GPi的DBS治疗。
- 在基线、6个月和12个月随访时进行临床结局评估,评估条件包括开药与关药、双侧刺激开与关及单侧STN刺激开。
主要发现
- 关药开机状态下,6个月和12个月随访时UPDRS-III和TUG评估的运动症状显著改善。
- 12个月随访时患者报告生活质量更好,且左旋多巴摄入量减少。
- 开药状态下,双侧刺激与中轴症状改善相关,12个月随访时步态与跌倒指标改善64%。
- 未观察到不可逆的不良事件。
临床怎么用
- 对于部分帕金森病患者,可考虑单侧STN联合对侧GPi的DBS以兼顾各靶点优势并减少副作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Subthalamic nucleus (STN) and globus pallidus interna (GPi) are the most effective targets in deep brain stimulation (DBS) treatment for Parkinson disease (PD). However, the individualized selection of targets remains a clinical challenge. OBJECTIVE: To combine unilateral STN and contralateral GPi stimulation (STN DBS in one brain hemisphere and GPi DBS in the other) to maximize the clinical advantages of each target while inducing fewer adverse side effects in selected patients with PD because each target has its own clinical effects and risk profiles. METHODS: We reviewed the clinical outcomes of 8 patients with idiopathic PD treated with combined unilateral STN and contralateral GPi DBS. Clinical outcome assessments, focusing on motor and nonmotor symptoms, were performed at baseline and 6-mo and 12-mo follow-up. We performed the assessments under the following conditions: medication on and off (bilateral stimulation on and off and unilateral STN stimulation on). RESULTS: Patients showed a significant improvement in motor symptoms, as assessed by the Unified Parkinson Disease Rating Scale III (UPDRS-III) and Timed Up-and-Go Test (TUG), in the off-medication/on-stimulation state at 6-mo and 12-mo follow-up. Also, patients reported a better quality of life, and their intake of levodopa was reduced at 12-mo follow-up. In the on-medication condition, bilateral stimulation was associated with an improvement in axial symptoms, with a 64% improvement in measures of gait and falls at 12-mo follow-up. No irreversible adverse side effects were observed. CONCLUSION: Our findings suggest that combined unilateral STN and contralateral GPi DBS could offer an effective and well-tolerated DBS treatment for certain PD patients.
引用
- Zhang C, Wang L, Hu W, et al. Combined Unilateral Subthalamic Nucleus and Contralateral Globus Pallidus Interna Deep Brain Stimulation for Treatment of Parkinson Disease: A Pilot Study of Symptom-Tailored Stimulation. Neurosurgery. 2020. PMID: 32459849. doi:10.1093/neuros/nyaa201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。